Incidence and spectrum of neonatal lupus erythematosus: A prospective study of infants born to mothers with anti-Ro autoantibodies

被引:165
作者
Cimaz, R
Spence, DL
Hornberger, L
Silverman, ED
机构
[1] ICP, Dept Pediat, I-20122 Milan, Italy
[2] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Rheumatol, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Cardiol, Toronto, ON M5G 1X8, Canada
[4] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada
关键词
D O I
10.1067/mpd.2003.233
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective Neonatal lupus erythematosus (NLE) is characterized by complete congenital heart block (CCHB), cutaneous rash, and laboratory abnormalities in infants born to mothers with autoantibodies directed against SSA/Ro, SSB/La, or both. We carried out a prospective study to determine the incidence of individual NLE features. Study design The study was performed in two centers: Toronto, Canada, and Milano, Italy. Mothers had been referred for the presence of anti-SSA/Ro autoantibodies, regardless of their diagnosis. All the children were seen at least once within the first 6 months of life for clinical evaluation and laboratory testing. The study group consisted of 128 infants born from 124 pregnancies in 112 women with anti-Ro antibodies with or without anti-La antibodies. Results There were two cases of CCHB for an overall percentage of 1.6%. Twenty-one children (16%) developed cutaneous NLE. Laboratory testing showed hematologic abnormalities in 27% of the babies and elevation of liver enzymes in 26%. Conclusions Mothers with autoimmune diseases and anti-Ro antibodies are at risk of delivering a child with NLE but at a low risk of delivering a child. with CCHB. Infants born to mothers with anti-Ro or anti-La antibodies should be monitored for other features of NLE in addition to CCHB.
引用
收藏
页码:678 / 683
页数:6
相关论文
共 34 条
[1]   Anti-re-associated sinus bradycardia in newborns [J].
Brucato, A ;
Cimaz, R ;
Catelli, L ;
Meroni, P .
CIRCULATION, 2000, 102 (11) :E88-E88
[2]  
Brucato A, 2001, ARTHRITIS RHEUM-US, V44, P1832, DOI 10.1002/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO
[3]  
2-C
[4]  
Buyon Jill P., 1996, Current Opinion in Rheumatology, V8, P485, DOI 10.1097/00002281-199609000-00016
[5]   Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry [J].
Buyon, JP ;
Hiebert, R ;
Copel, J ;
Craft, J ;
Friedman, D ;
Katholi, M ;
Lee, LA ;
Provost, TT ;
Reichlin, M ;
Rider, L ;
Rupel, A ;
Saleeb, S ;
Weston, WL ;
Skovron, ML .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (07) :1658-1666
[6]   Transient neonatal bradycardia without heart block associated with anti-Ro antibodies [J].
Cimaz, R ;
Airoldi, ML ;
Careddu, P ;
Centinaio, G ;
Catelli, L ;
Franceschini, F ;
Meroni, PL .
LUPUS, 1997, 6 (05) :487-488
[7]  
Cimaz R, 2000, ARTHRITIS RHEUM, V43, P1049, DOI 10.1002/1529-0131(200005)43:5<1049::AID-ANR13>3.0.CO
[8]  
2-X
[9]  
Cimaz R, 2000, ISR MED ASSOC J, V2, P228
[10]  
Franceschini F, 1999, CLIN EXP RHEUMATOL, V17, P634